Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2002 Jan;8(1):63-8.
doi: 10.3201/eid0801.000454.

Antimicrobial drug resistance in pathogens causing nosocomial infections at a university hospital in Taiwan, 1981-1999

Affiliations

Antimicrobial drug resistance in pathogens causing nosocomial infections at a university hospital in Taiwan, 1981-1999

Po-Ren Hsueh et al. Emerg Infect Dis. 2002 Jan.

Abstract

To determine the distribution and antimicrobial drug resistance in bacterial pathogens causing nosocomial infections, surveillance data on nosocomial infections documented from 1981 to 1999 at National Taiwan University Hospital were analyzed. During this period, 35,580 bacterial pathogens causing nosocomial infections were identified. Candida species increased considerably, ranking first by 1999 in the incidence of pathogens causing all nosocomial infections, followed by Staphylococcus aureus and Pseudomonas aeruginosa. Candida species also increased in importance as bloodstream infection isolates, from 1.0% in 1981-1986 to 16.2% in 1999. The most frequent isolates from urinary tract infections were Candida species (23.6%), followed by Escherichia coli (18.6%) and P. aeruginosa (11.0%). P. aeruginosa remained the most frequent isolates for respiratory tract and surgical site infections in the past 13 years. A remarkable increase in incidence was found in methicillin-resistant S. aureus (from 4.3% in 1981-1986 to 58.9% in 1993-1998), cefotaxime-resistant E. coli (from 0% in 1981-1986 to 6.1% in 1993-1998), and cefotaxime-resistant Klebsiella pneumoniae (from 4.0% in 1981-1986 to 25.8% in 1993-1998). Etiologic shifts in nosocomial infections and an upsurge of antimicrobial resistance among these pathogens, particularly those isolated from intensive care units, are impressive and alarming.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Rates of four major nosocomial infections expressed as number of infections per 10,000 patient-days at National Taiwan University Hospital from 1991 to 1999. BSI, bloodstream infection; UTI, urinary tract infection; SSI, surgical site infection; RTI, respiratory tract infection.
Figure 2
Figure 2
Changes in major antimicrobial-resistant nosocomial pathogens in relation to ceftazidime use at National Taiwan University Hospital from 1991 to 1999.
Figure 3
Figure 3
Incidences of vancomycin-resistant enterococci (VRE) among all enterococcal isolates causing nosocomial infections in relation to vancomycin use at National Taiwan University Hospital, 1995-1999. Numbers above the bars denote the number of enterococcal isolates causing nosocomial infections. Numbers within the bars denote the numbers of VRE.
Figure 4
Figure 4
Proportions of Pseudomonas aeruginosa (A) and Acinetobacter baumannii (B) isolates causing nosocomial infections resistant to imipenem in National Taiwan University Hospital, 1993-1999. ICU = intensive care unit.

References

    1. Archibald L, Phillips L, Monnet D, McGowan JE Jr, Tenover FC, Gaynes RP. Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit. Clin Infect Dis. 1997;24:211–5. - PubMed
    1. CDC NNIS System. National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1990-May 1999, issued June 1999. Am J Infect Control. 1999;27:520–32. 10.1016/S0196-6553(99)70031-3 - DOI - PubMed
    1. Emori TG, Gaynes RP. An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev. 1993;6:428–42. - PMC - PubMed
    1. Fridkin SK, Steward CD, Edwards JR. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Clin Infect Dis. 1999;29:245–52. 10.1086/520193 - DOI - PubMed
    1. Sahm DF, Marsillio MK, Piazza G. Antimicrobial resistance in key bloodstream bacterial isolates: electronic surveillance with the surveillance network database-USA. Clin Infect Dis. 1999;29:259–63. 10.1086/520195 - DOI - PubMed

MeSH terms

LinkOut - more resources